PARICALCITOL
Clinical Indication
Secondary hyperparathyroidism in renal failure
Date of classification
February 2010
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.